"RedShiftBio provides a next-generation infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality."
AQS3pro Microfluidic Modulation Spectrometer
The Next Generation in Protein Characterization
The AQS3pro brings protein secondary structure measurement into every stage of the biopharmaceutical pipeline. Measuring in conditions that were previously not possible with traditional methods, MMS provides repeatable, high sensitivity, automated measurement across a wide concentration range, in any formulation.
See change in your protein, in your workflow, and in your efficiency.
Higher Order Structure (HOS) 2020, Apr 20-22, Gaithersburg, MD - CANCELED
13th Annual Proteins & Antibodies Congress, Apr 27-29, London, UK - POSTPONED
PEGS, May 4-8, Boston, MA
ASMS, May 31 - June 4, Houston, TX
Well Characterized Biologics and Biological Assays, Oct 27-29, Hyattsville, MD
PEGS EU, Nov 2020, Lisbon, Portugal
RedShift™, RedShiftBio®, See Change®, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.